| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | type 2 fibroblast growth factor receptor binding | 7.68e-05 | 5 | 56 | 2 | GO:0005111 | |
| GeneOntologyMolecularFunction | type 1 fibroblast growth factor receptor binding | 1.15e-04 | 6 | 56 | 2 | GO:0005105 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 1.64e-04 | 38 | 56 | 3 | GO:0000146 | |
| GeneOntologyMolecularFunction | actin filament binding | 4.33e-04 | 227 | 56 | 5 | GO:0051015 | |
| MousePheno | thoracic vertebral transformation | 2.72e-05 | 51 | 48 | 4 | MP:0004618 | |
| Domain | IQ | 9.07e-11 | 81 | 55 | 8 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 2.14e-10 | 90 | 55 | 8 | IPR000048 | |
| Domain | IQ | 1.01e-08 | 93 | 55 | 7 | PS50096 | |
| Domain | IQ | 6.09e-08 | 71 | 55 | 6 | PF00612 | |
| Domain | Homeobox_metazoa | 6.68e-06 | 90 | 55 | 5 | IPR020479 | |
| Domain | CG-1 | 8.51e-06 | 2 | 55 | 2 | PF03859 | |
| Domain | CG-1 | 8.51e-06 | 2 | 55 | 2 | SM01076 | |
| Domain | CG-1_dom | 8.51e-06 | 2 | 55 | 2 | IPR005559 | |
| Domain | CG_1 | 8.51e-06 | 2 | 55 | 2 | PS51437 | |
| Domain | Homeobox_Antennapedia_CS | 3.10e-05 | 21 | 55 | 3 | IPR001827 | |
| Domain | ANTENNAPEDIA | 4.68e-05 | 24 | 55 | 3 | PS00032 | |
| Domain | TIG | 1.02e-04 | 31 | 55 | 3 | PF01833 | |
| Domain | IPT | 1.13e-04 | 32 | 55 | 3 | IPR002909 | |
| Domain | Myosin_head_motor_dom | 1.89e-04 | 38 | 55 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.89e-04 | 38 | 55 | 3 | PS51456 | |
| Domain | Myosin_head | 1.89e-04 | 38 | 55 | 3 | PF00063 | |
| Domain | MYSc | 1.89e-04 | 38 | 55 | 3 | SM00242 | |
| Domain | Homeobox_CS | 2.16e-04 | 186 | 55 | 5 | IPR017970 | |
| Domain | Na_channel_asu | 3.77e-04 | 10 | 55 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 3.77e-04 | 10 | 55 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 3.77e-04 | 10 | 55 | 2 | PF06512 | |
| Domain | Homeobox | 6.18e-04 | 234 | 55 | 5 | PF00046 | |
| Domain | HOMEOBOX_1 | 6.42e-04 | 236 | 55 | 5 | PS00027 | |
| Domain | HOX | 6.54e-04 | 237 | 55 | 5 | SM00389 | |
| Domain | HOMEOBOX_2 | 6.80e-04 | 239 | 55 | 5 | PS50071 | |
| Domain | Homeobox_dom | 6.80e-04 | 239 | 55 | 5 | IPR001356 | |
| Domain | - | 1.44e-03 | 283 | 55 | 5 | 1.10.10.60 | |
| Domain | UIM | 1.72e-03 | 21 | 55 | 2 | SM00726 | |
| Domain | MHC_I | 1.72e-03 | 21 | 55 | 2 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 1.72e-03 | 21 | 55 | 2 | IPR001039 | |
| Domain | FGF | 1.89e-03 | 22 | 55 | 2 | SM00442 | |
| Domain | FGF | 1.89e-03 | 22 | 55 | 2 | PF00167 | |
| Domain | HBGF_FGF | 1.89e-03 | 22 | 55 | 2 | PS00247 | |
| Domain | Fibroblast_GF_fam | 1.89e-03 | 22 | 55 | 2 | IPR002209 | |
| Domain | IL-1_fam/FGF_fam | 2.07e-03 | 23 | 55 | 2 | IPR028142 | |
| Domain | UIM_dom | 2.45e-03 | 25 | 55 | 2 | IPR003903 | |
| Domain | Homeodomain-like | 2.89e-03 | 332 | 55 | 5 | IPR009057 | |
| Domain | Ig_E-set | 3.57e-03 | 104 | 55 | 3 | IPR014756 | |
| Domain | Cytokine_IL1-like | 5.03e-03 | 36 | 55 | 2 | IPR008996 | |
| Pathway | REACTOME_FGFR3B_LIGAND_BINDING_AND_ACTIVATION | 1.47e-04 | 7 | 38 | 2 | M27064 | |
| Pathway | REACTOME_FGFR3B_LIGAND_BINDING_AND_ACTIVATION | 1.47e-04 | 7 | 38 | 2 | MM14726 | |
| Pathway | REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1 | 3.83e-04 | 11 | 38 | 2 | M675 | |
| Pathway | REACTOME_SEROTONIN_RECEPTORS | 3.83e-04 | 11 | 38 | 2 | MM15008 | |
| Pathway | REACTOME_SEROTONIN_RECEPTORS | 4.59e-04 | 12 | 38 | 2 | M6034 | |
| Pathway | REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION | 4.59e-04 | 12 | 38 | 2 | MM14728 | |
| Pathway | REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING | 5.42e-04 | 13 | 38 | 2 | M27540 | |
| Pathway | REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION | 5.42e-04 | 13 | 38 | 2 | M1087 | |
| Pathway | REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING | 5.42e-04 | 13 | 38 | 2 | MM15262 | |
| Pathway | REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION | 5.42e-04 | 13 | 38 | 2 | M27061 | |
| Pathway | REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION | 5.42e-04 | 13 | 38 | 2 | MM14723 | |
| Pathway | REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION | 5.42e-04 | 13 | 38 | 2 | MM14727 | |
| Pathway | REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION | 6.31e-04 | 14 | 38 | 2 | M27065 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4 | 7.27e-04 | 15 | 38 | 2 | M27509 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4 | 7.27e-04 | 15 | 38 | 2 | MM15235 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR1 | 8.29e-04 | 16 | 38 | 2 | M48007 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR1 | 8.29e-04 | 16 | 38 | 2 | MM15233 | |
| Pathway | REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION | 9.38e-04 | 17 | 38 | 2 | MM17066 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2 | 9.38e-04 | 17 | 38 | 2 | MM15234 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR3 | 9.38e-04 | 17 | 38 | 2 | MM15244 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2 | 1.05e-03 | 18 | 38 | 2 | M27508 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR3 | 1.05e-03 | 18 | 38 | 2 | M27518 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR3 | 1.05e-03 | 18 | 38 | 2 | M27521 | |
| Pathway | REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION | 1.05e-03 | 18 | 38 | 2 | M1092 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR3 | 1.05e-03 | 18 | 38 | 2 | MM15247 | |
| Pathway | REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION | 1.05e-03 | 18 | 38 | 2 | MM14724 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR4 | 1.18e-03 | 19 | 38 | 2 | MM15250 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR3_SIGNALING | 1.18e-03 | 19 | 38 | 2 | MM15245 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR3_SIGNALING | 1.30e-03 | 20 | 38 | 2 | M27519 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR4 | 1.30e-03 | 20 | 38 | 2 | M27525 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR4 | 1.30e-03 | 20 | 38 | 2 | M27524 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR4 | 1.30e-03 | 20 | 38 | 2 | MM15251 | |
| Pathway | REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION | 1.30e-03 | 20 | 38 | 2 | M27062 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR1 | 1.30e-03 | 20 | 38 | 2 | MM15237 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR1 | 1.44e-03 | 21 | 38 | 2 | M27512 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR1 | 1.44e-03 | 21 | 38 | 2 | M27511 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR1 | 1.44e-03 | 21 | 38 | 2 | MM15238 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR4_SIGNALING | 1.44e-03 | 21 | 38 | 2 | MM15248 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR2 | 1.44e-03 | 21 | 38 | 2 | MM15242 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR4_SIGNALING | 1.58e-03 | 22 | 38 | 2 | M27522 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR1_SIGNALING | 1.58e-03 | 22 | 38 | 2 | MM15239 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR2 | 1.58e-03 | 22 | 38 | 2 | MM15240 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR2 | 1.73e-03 | 23 | 38 | 2 | M27514 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR1_SIGNALING | 1.73e-03 | 23 | 38 | 2 | M27513 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR2_SIGNALING | 1.73e-03 | 23 | 38 | 2 | MM15243 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3 | 1.88e-03 | 24 | 38 | 2 | MM15246 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR2_SIGNALING | 2.04e-03 | 25 | 38 | 2 | M27517 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3 | 2.04e-03 | 25 | 38 | 2 | M27520 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4 | 2.21e-03 | 26 | 38 | 2 | MM15249 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4 | 2.38e-03 | 27 | 38 | 2 | M27523 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2 | 2.56e-03 | 28 | 38 | 2 | MM15241 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING | 2.74e-03 | 29 | 38 | 2 | M27528 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING | 2.74e-03 | 29 | 38 | 2 | MM15253 | |
| Pathway | WP_DOPAMINERGIC_NEUROGENESIS | 2.93e-03 | 30 | 38 | 2 | M39580 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2 | 2.93e-03 | 30 | 38 | 2 | M27515 | |
| Pathway | WP_DOPAMINERGIC_NEUROGENESIS | 2.93e-03 | 30 | 38 | 2 | MM15831 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1 | 2.93e-03 | 30 | 38 | 2 | MM15236 | |
| Pathway | REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION | 3.13e-03 | 31 | 38 | 2 | M661 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY | 3.13e-03 | 31 | 38 | 2 | M47396 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1 | 3.13e-03 | 31 | 38 | 2 | M27510 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING | 3.13e-03 | 31 | 38 | 2 | M27529 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING | 3.13e-03 | 31 | 38 | 2 | MM15254 | |
| Pathway | WP_MONOAMINE_GPCRS | 3.13e-03 | 31 | 38 | 2 | MM15871 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 3.13e-03 | 31 | 38 | 2 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 3.33e-03 | 32 | 38 | 2 | M27455 | |
| Pathway | WP_MONOAMINE_GPCRS | 3.54e-03 | 33 | 38 | 2 | M39585 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING | 3.54e-03 | 33 | 38 | 2 | M27526 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING | 3.54e-03 | 33 | 38 | 2 | MM15252 | |
| Pathway | REACTOME_FGFR2_MUTANT_RECEPTOR_ACTIVATION | 3.54e-03 | 33 | 38 | 2 | M27049 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING | 3.76e-03 | 34 | 38 | 2 | M27527 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY | 3.98e-03 | 35 | 38 | 2 | M47379 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE | 4.68e-03 | 38 | 38 | 2 | M27536 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR3 | 4.92e-03 | 39 | 38 | 2 | MM15257 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR3 | 5.17e-03 | 40 | 38 | 2 | M27532 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4 | 5.17e-03 | 40 | 38 | 2 | MM15258 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4 | 5.43e-03 | 41 | 38 | 2 | M27533 | |
| Pathway | REACTOME_IRS_MEDIATED_SIGNALLING | 5.43e-03 | 41 | 38 | 2 | MM14505 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 5.69e-03 | 42 | 38 | 2 | M5868 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 5.69e-03 | 42 | 38 | 2 | MM14971 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE | 5.96e-03 | 43 | 38 | 2 | M27534 | |
| Pathway | WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION | 6.80e-03 | 46 | 38 | 2 | M46450 | |
| Pathway | REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R | 7.09e-03 | 47 | 38 | 2 | MM14885 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 7.38e-03 | 48 | 38 | 2 | MM15441 | |
| Pathway | REACTOME_IRS_MEDIATED_SIGNALLING | 7.38e-03 | 48 | 38 | 2 | M26916 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1 | 7.99e-03 | 50 | 38 | 2 | MM15255 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1 | 8.62e-03 | 52 | 38 | 2 | M27530 | |
| Pathway | REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R | 9.27e-03 | 54 | 38 | 2 | M27168 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 9.27e-03 | 54 | 38 | 2 | M620 | |
| Pathway | REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA | 9.60e-03 | 55 | 38 | 2 | M41823 | |
| Pathway | PID_FGF_PATHWAY | 9.60e-03 | 55 | 38 | 2 | M276 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 9.60e-03 | 55 | 38 | 2 | M47952 | |
| Pubmed | Cdx and T Brachyury Co-activate Growth Signaling in the Embryonic Axial Progenitor Niche. | 5.68e-09 | 40 | 56 | 5 | 28009287 | |
| Pubmed | 6.46e-09 | 41 | 56 | 5 | 32479258 | ||
| Pubmed | Enhancer timing of Hox gene expression: deletion of the endogenous Hoxc8 early enhancer. | 1.58e-08 | 4 | 56 | 3 | 12917291 | |
| Pubmed | Altering the spatial determinations in the mouse embryos by manipulating the Hox genes. | 1.58e-08 | 4 | 56 | 3 | 7915631 | |
| Pubmed | New insights into the role of Jmjd3 and Utx in axial skeletal formation in mice. | 1.81e-08 | 50 | 56 | 5 | 28188179 | |
| Pubmed | 4.31e-08 | 22 | 56 | 4 | 2576652 | ||
| Pubmed | 6.25e-08 | 24 | 56 | 4 | 9367423 | ||
| Pubmed | 8.77e-08 | 26 | 56 | 4 | 8646877 | ||
| Pubmed | Critical role of the p400/mDomino chromatin-remodeling ATPase in embryonic hematopoiesis. | 2.10e-07 | 32 | 56 | 4 | 17535249 | |
| Pubmed | Sf3b4 regulates chromatin remodeler splicing and Hox expression. | 2.10e-07 | 32 | 56 | 4 | 37167859 | |
| Pubmed | 4.27e-07 | 38 | 56 | 4 | 15042701 | ||
| Pubmed | 4.27e-07 | 38 | 56 | 4 | 11857506 | ||
| Pubmed | 4.75e-07 | 39 | 56 | 4 | 33257809 | ||
| Pubmed | Quantification of Hox and surfactant protein-B transcription during murine lung development. | 5.27e-07 | 40 | 56 | 4 | 19204410 | |
| Pubmed | 7.10e-07 | 43 | 56 | 4 | 22701719 | ||
| Pubmed | 7.80e-07 | 44 | 56 | 4 | 1973146 | ||
| Pubmed | 1.02e-06 | 47 | 56 | 4 | 1358459 | ||
| Pubmed | 1.42e-06 | 14 | 56 | 3 | 8099712 | ||
| Pubmed | 2.18e-06 | 16 | 56 | 3 | 16624538 | ||
| Pubmed | 2.18e-06 | 16 | 56 | 3 | 7768176 | ||
| Pubmed | Ataxia and Purkinje cell degeneration in mice lacking the CAMTA1 transcription factor. | 2.55e-06 | 2 | 56 | 2 | 25049392 | |
| Pubmed | A novel family of calmodulin-binding transcription activators in multicellular organisms. | 2.55e-06 | 2 | 56 | 2 | 11925432 | |
| Pubmed | 2.65e-06 | 17 | 56 | 3 | 21471156 | ||
| Pubmed | 2.65e-06 | 17 | 56 | 3 | 17626057 | ||
| Pubmed | 3.17e-06 | 18 | 56 | 3 | 23359544 | ||
| Pubmed | The mouse PcG gene eed is required for Hox gene repression and extraembryonic development. | 4.42e-06 | 20 | 56 | 3 | 12370779 | |
| Pubmed | 5.15e-06 | 21 | 56 | 3 | 12399319 | ||
| Pubmed | Crypto-rhombomeres of the mouse medulla oblongata, defined by molecular and morphological features. | 5.15e-06 | 21 | 56 | 3 | 25381007 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 21319186 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 9651520 | ||
| Pubmed | Motor neuron columnar fate imposed by sequential phases of Hox-c activity. | 7.63e-06 | 3 | 56 | 2 | 14586461 | |
| Pubmed | Frontal cortex subdivision patterning is coordinately regulated by Fgf8, Fgf17, and Emx2. | 7.63e-06 | 3 | 56 | 2 | 18459137 | |
| Pubmed | 1.00e-05 | 26 | 56 | 3 | 17150206 | ||
| Pubmed | 1.13e-05 | 27 | 56 | 3 | 18480159 | ||
| Pubmed | 1.40e-05 | 29 | 56 | 3 | 2574852 | ||
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 10198179 | ||
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 2570032 | ||
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 16384934 | ||
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 25889070 | ||
| Pubmed | Multiple roles of mesenchymal beta-catenin during murine limb patterning. | 1.56e-05 | 30 | 56 | 3 | 16495310 | |
| Pubmed | GDE2 regulates subtype-specific motor neuron generation through inhibition of Notch signaling. | 1.56e-05 | 30 | 56 | 3 | 21943603 | |
| Pubmed | 1.90e-05 | 32 | 56 | 3 | 26441343 | ||
| Pubmed | 2.08e-05 | 33 | 56 | 3 | 18662545 | ||
| Pubmed | 2.49e-05 | 35 | 56 | 3 | 28031476 | ||
| Pubmed | 2.54e-05 | 5 | 56 | 2 | 25318670 | ||
| Pubmed | 2.54e-05 | 5 | 56 | 2 | 17965051 | ||
| Pubmed | 2.54e-05 | 5 | 56 | 2 | 32907848 | ||
| Pubmed | Global control of motor neuron topography mediated by the repressive actions of a single hox gene. | 2.72e-05 | 36 | 56 | 3 | 20826310 | |
| Pubmed | 3.20e-05 | 38 | 56 | 3 | 1683707 | ||
| Pubmed | 3.74e-05 | 40 | 56 | 3 | 21256124 | ||
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 16470835 | ||
| Pubmed | Generation of conditional Hoxc8 loss-of-function and Hoxc8-->Hoxc9 replacement alleles in mice. | 3.80e-05 | 6 | 56 | 2 | 19621436 | |
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 7918106 | ||
| Pubmed | Genomic structure, mapping, activity and expression of fibroblast growth factor 17. | 3.80e-05 | 6 | 56 | 2 | 10381577 | |
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 19732411 | ||
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 23935987 | ||
| Pubmed | Molecular characterization, structure and developmental expression of Megane bHLH factor. | 3.80e-05 | 6 | 56 | 2 | 16644143 | |
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 9242489 | ||
| Pubmed | 4.04e-05 | 118 | 56 | 4 | 16971476 | ||
| Pubmed | 4.90e-05 | 124 | 56 | 4 | 35516420 | ||
| Pubmed | 4.90e-05 | 407 | 56 | 6 | 12693553 | ||
| Pubmed | 5.32e-05 | 7 | 56 | 2 | 11953986 | ||
| Pubmed | 5.32e-05 | 7 | 56 | 2 | 10722873 | ||
| Pubmed | 5.32e-05 | 7 | 56 | 2 | 24651482 | ||
| Pubmed | Developmental origins of precocial forelimbs in marsupial neonates. | 5.32e-05 | 7 | 56 | 2 | 21098569 | |
| Pubmed | FGF8 acts as a classic diffusible morphogen to pattern the neocortex. | 5.32e-05 | 7 | 56 | 2 | 20843859 | |
| Pubmed | 5.32e-05 | 7 | 56 | 2 | 12915301 | ||
| Pubmed | Conditional inactivation of Fgf4 reveals complexity of signalling during limb bud development. | 7.09e-05 | 8 | 56 | 2 | 10802662 | |
| Pubmed | 7.09e-05 | 8 | 56 | 2 | 1976088 | ||
| Pubmed | 7.09e-05 | 8 | 56 | 2 | 14602678 | ||
| Pubmed | 7.09e-05 | 8 | 56 | 2 | 23527240 | ||
| Pubmed | Extent of the mouse t complex and its inversions shown by in situ hybridization. | 7.09e-05 | 8 | 56 | 2 | 3356450 | |
| Pubmed | A genome-wide association study of the Protein C anticoagulant pathway. | 7.09e-05 | 8 | 56 | 2 | 22216198 | |
| Pubmed | 7.09e-05 | 8 | 56 | 2 | 15255957 | ||
| Pubmed | Altered cellular proliferation and mesoderm patterning in Polycomb-M33-deficient mice. | 9.10e-05 | 9 | 56 | 2 | 9043087 | |
| Pubmed | 9.10e-05 | 9 | 56 | 2 | 17537797 | ||
| Pubmed | 9.10e-05 | 9 | 56 | 2 | 9139660 | ||
| Pubmed | 9.10e-05 | 9 | 56 | 2 | 23643382 | ||
| Pubmed | Autocrine and paracrine mechanisms regulating primordial germ cell proliferation. | 9.10e-05 | 9 | 56 | 2 | 15039943 | |
| Pubmed | 9.10e-05 | 9 | 56 | 2 | 19793884 | ||
| Pubmed | 9.10e-05 | 9 | 56 | 2 | 24155669 | ||
| Pubmed | 9.10e-05 | 9 | 56 | 2 | 19339464 | ||
| Pubmed | Identification of the murine Hox-c12 and Hox-c13 homeoboxes on yeast artificial chromosomes. | 9.10e-05 | 9 | 56 | 2 | 7959778 | |
| Pubmed | 9.25e-05 | 54 | 56 | 3 | 22266860 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 9.81e-05 | 908 | 56 | 8 | 19274049 | |
| Pubmed | Expression and functional analysis of Tgif during mouse midline development. | 1.14e-04 | 10 | 56 | 2 | 16284942 | |
| Pubmed | Genetic evidence that FGFs have an instructive role in limb proximal-distal patterning. | 1.14e-04 | 10 | 56 | 2 | 18449196 | |
| Pubmed | 1.14e-04 | 10 | 56 | 2 | 18498097 | ||
| Pubmed | 1.14e-04 | 10 | 56 | 2 | 25912421 | ||
| Pubmed | 1.14e-04 | 10 | 56 | 2 | 19625254 | ||
| Pubmed | 1.14e-04 | 10 | 56 | 2 | 15470137 | ||
| Pubmed | 1.14e-04 | 10 | 56 | 2 | 29213092 | ||
| Pubmed | 1.14e-04 | 10 | 56 | 2 | 21451961 | ||
| Pubmed | The canonical Wnt/β-catenin signaling pathway regulates Fgf signaling for early facial development. | 1.14e-04 | 10 | 56 | 2 | 21070765 | |
| Pubmed | Mesenchymal Hox6 function is required for mouse pancreatic endocrine cell differentiation. | 1.21e-04 | 59 | 56 | 3 | 26450967 | |
| Pubmed | 1.39e-04 | 11 | 56 | 2 | 18199118 | ||
| Pubmed | 1.39e-04 | 11 | 56 | 2 | 18855532 | ||
| Pubmed | 1.39e-04 | 11 | 56 | 2 | 24697898 | ||
| Pubmed | Cognate homeo-box loci mapped on homologous human and mouse chromosomes. | 1.39e-04 | 11 | 56 | 2 | 2878432 | |
| Pubmed | Emx2 patterns the neocortex by regulating FGF positional signaling. | 1.39e-04 | 11 | 56 | 2 | 12872126 | |
| Interaction | PSME3 interactions | 1.17e-05 | 398 | 55 | 8 | int:PSME3 | |
| Cytoband | 11q13.2 | 1.53e-03 | 47 | 56 | 2 | 11q13.2 | |
| Cytoband | 12q13.3 | 1.79e-03 | 51 | 56 | 2 | 12q13.3 | |
| GeneFamily | HOXL subclass homeoboxes | 1.81e-06 | 52 | 31 | 4 | 518 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 2.19e-04 | 13 | 31 | 2 | 170 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Crispld2_(Neuron.Gad1Gad2.Synpr-Crispld2)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.56e-06 | 67 | 56 | 4 | f117cec517d15bff2d4b963c5791877426272631 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Crispld2_(Neuron.Gad1Gad2.Synpr-Crispld2)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.56e-06 | 67 | 56 | 4 | df06046269894edbc872b48b9eccb458f6be8cf2 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-06 | 161 | 56 | 5 | 441ebd3c029861d833fbcf8a68fc740d9de8ef2f | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.24e-06 | 168 | 56 | 5 | d60f7cd8269f373827f49c7785002cb38e4570a9 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.31e-06 | 169 | 56 | 5 | ccd98f9005aa0a88bd49f153be4e7200cc3dd0ac | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Chrm2_(Cerebellum_basket_cells_4)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.17e-06 | 80 | 56 | 4 | 54f520cca126810510479fbeade2e3f66fb5dd1b | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Chrm2_(Cerebellum_basket_cells_4)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.17e-06 | 80 | 56 | 4 | ce38ea123853a1e1082a033fb779b63ea440661d | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.31e-06 | 182 | 56 | 5 | 04ccfa951eaa31fed6d140edb6c702d49363c5fa | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.68e-06 | 186 | 56 | 5 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | IPF-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 3.88e-06 | 188 | 56 | 5 | 47bb6caf84f70a1cda7d09803afdfd5182772e66 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-DC2|Lung / Manually curated celltypes from each tissue | 4.09e-06 | 190 | 56 | 5 | 468525c05e38158a3b8a445882b2d63dfb1d2c63 | |
| ToppCell | LAM-Myeloid-DC|Myeloid / Condition, Lineage and Cell class | 4.41e-06 | 193 | 56 | 5 | f665cce40053ae5d6e28f9f70ddf78e8598c9514 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-DC2|Lung / Manually curated celltypes from each tissue | 4.41e-06 | 193 | 56 | 5 | c97f9b13057f803df63c696c6175ef8e0aba6fa7 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic|Lung / Manually curated celltypes from each tissue | 4.41e-06 | 193 | 56 | 5 | 7bce609699c515d2d114596a0c527f90cc09c4af | |
| ToppCell | (010)_cDC|World / immune cells in Peripheral Blood (logTPM normalization) | 4.64e-06 | 195 | 56 | 5 | 4aabb3f5ce70100e4d98d7fa9f8d12e84fb9fe3d | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.75e-06 | 196 | 56 | 5 | b15812354128c12a588d79ef449d787e74835f3b | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.25e-06 | 200 | 56 | 5 | 36de49593cf6ff1c9229fcceb150c1d68658a360 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.25e-05 | 113 | 56 | 4 | 79ba2eb8f85e5da4c19c838df881c18ffdc450fb | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.25e-05 | 113 | 56 | 4 | 91d55fe6fb1c1472867d74461f5b9e4f17db01cd | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.25e-05 | 113 | 56 | 4 | 34ae3dec5ec7585d155ea61de6adc42aa4f45226 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.86e-05 | 125 | 56 | 4 | a72891c3fb9cdefa9254f8e2e3c4ffa6fc3a5ffc | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Slc24a2_(Deep_layer_pyramidal_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.33e-05 | 44 | 56 | 3 | 405ac4aeee539322cfe661c7531248f81271be8d | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Slc24a2_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.33e-05 | 44 | 56 | 3 | a2c99e8ca635590a1f167b68bc390e2aa01e26be | |
| ToppCell | severe_COVID-19-cDC|World / disease group, cell group and cell class (v2) | 4.44e-05 | 156 | 56 | 4 | 0a7e18ed8e13261c405eb6b9a183e99d8e1aac37 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_macrophage-microglial_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.55e-05 | 157 | 56 | 4 | d4908cafd8870c1c225817f589ea2bce116ac7ab | |
| ToppCell | severe_COVID-19-cDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 4.55e-05 | 157 | 56 | 4 | ec1978e07e2214048d015d8bb793c1d9991f6e37 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2) | 5.79e-05 | 167 | 56 | 4 | bf08f17965a4dd03f371b4ed0ab0d5e62ed61307 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 5.92e-05 | 168 | 56 | 4 | 968405ea56f7d001ef83ff9274610923c3b2d55d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.06e-05 | 169 | 56 | 4 | 0867528101767fc65e93b3561480bf830c50368d | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-05 | 171 | 56 | 4 | 4a2e6ea9674bf23e8012ef0bb2bf19ce1f55fcd5 | |
| ToppCell | control-Myeloid-Monocyte-derived_Macrophage|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.34e-05 | 171 | 56 | 4 | e828b684744a4fdf6b63ec033c4f000b39ca0d51 | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-05 | 171 | 56 | 4 | 5b74df72e36ad04dfb25c72f1ca8efe043f6cda6 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-05 | 172 | 56 | 4 | 72fbfa890995e47048b47199c170cc7dcd7661f8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-05 | 172 | 56 | 4 | 2ca6f0d1181aabe0d0e3e8f2e193f08dbda42dea | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.63e-05 | 173 | 56 | 4 | 7e3897868dd3f6e4974f593c60649a543ffc8693 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.63e-05 | 173 | 56 | 4 | 9a3500b06d00d1d4ee42910a3a73327b21beab52 | |
| ToppCell | NS-control-d_0-4-Myeloid-Monocyte-derived_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.78e-05 | 174 | 56 | 4 | 758984730cd1c3ccf6866a3a8f03d6e002f3edb6 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(RGS5+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.94e-05 | 175 | 56 | 4 | f5451c29c487b998778e50349b3d774d5e20fd28 | |
| ToppCell | COVID-19-Myeloid-MoAM4|COVID-19 / Condition, Lineage and Cell class | 7.25e-05 | 177 | 56 | 4 | ca5d0c3d5c700bbe4c2da068eb02be6229afb9a0 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.25e-05 | 177 | 56 | 4 | 345cebc19f93970a9a46be139208b300081f5493 | |
| ToppCell | PSB-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.41e-05 | 178 | 56 | 4 | 45bdbb96094c97756e1b6eebd80eadd8472143f2 | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Dendritic|GI_large-bowel / Manually curated celltypes from each tissue | 7.74e-05 | 180 | 56 | 4 | 400f48aa2851d89bf3b60d721bc0f635f3ad86eb | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Dendritic-DC2|GI_large-bowel / Manually curated celltypes from each tissue | 7.74e-05 | 180 | 56 | 4 | d4ebe67a2735e244c08b238320bbb441ca88ee6f | |
| ToppCell | Severe-Myeloid-mDC|Severe / Condition, Lineage, Cell class and cell subclass | 7.90e-05 | 181 | 56 | 4 | 00f2949b609ac21bd2da6fd8f685739eeb2f48ad | |
| ToppCell | Severe-Myeloid-mDC-|Severe / Condition, Lineage, Cell class and cell subclass | 7.90e-05 | 181 | 56 | 4 | 51ded98c76ec35ab1d24ac3ab98280381daa9831 | |
| ToppCell | tumor_Lung-Myeloid_cells-CD207+CD1a+_LCs|tumor_Lung / Location, Cell class and cell subclass | 8.07e-05 | 182 | 56 | 4 | 243779ba1009097f8fafa1a691e296ec3aeefc04 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.07e-05 | 182 | 56 | 4 | 587636c0f127231de21acd8aa632b74ff22ca8c2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.07e-05 | 182 | 56 | 4 | adfadd7893e74b3002f13f00875e3667d3493e0c | |
| ToppCell | COVID-19-APC-like-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 8.25e-05 | 183 | 56 | 4 | 703364836b42aa6ac6c68b42b700ac23c4a1afc7 | |
| ToppCell | Dendritic_Cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 8.25e-05 | 183 | 56 | 4 | dd09e39e8ca282ff0f470e0652d519e190badd0b | |
| ToppCell | Control-APC-like-Dendritic_cells|Control / group, cell type (main and fine annotations) | 8.25e-05 | 183 | 56 | 4 | 8f9c8e2436f18ea7c265b08e4e149e19cb513a16 | |
| ToppCell | Control-APC-like|Control / group, cell type (main and fine annotations) | 8.25e-05 | 183 | 56 | 4 | c313ac72cc9fa1583456d452393f61f0a4ca33a8 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-DC2|bone_marrow / Manually curated celltypes from each tissue | 8.25e-05 | 183 | 56 | 4 | f482e4fe011fa450a475034b1e25587233855bdb | |
| ToppCell | COVID-19-APC-like|COVID-19 / group, cell type (main and fine annotations) | 8.25e-05 | 183 | 56 | 4 | b8f5afaf9ff1b2b1bc60be58654d1b23859dafa9 | |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 8.42e-05 | 184 | 56 | 4 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.42e-05 | 184 | 56 | 4 | 0a26bcc6610f756939e32a4d6dfeebcbf3a1db86 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD163+CD14+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 8.42e-05 | 184 | 56 | 4 | 2dc4b2a9970111ed5e2977fc178595a12d7bb59d | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.60e-05 | 185 | 56 | 4 | fec16a5e527fdef32d25957451b6e8ee9796cafd | |
| ToppCell | Control-Myeloid-cDC1|Control / Disease state, Lineage and Cell class | 8.78e-05 | 186 | 56 | 4 | b05c394aa3573ba855abc3066739ca193883b0c3 | |
| ToppCell | 3'_v3-blood-Myeloid_Dendritic-DC2|blood / Manually curated celltypes from each tissue | 8.96e-05 | 187 | 56 | 4 | 9f3db9f0e5de34aeabfe5984f675bc7a65435df7 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.15e-05 | 188 | 56 | 4 | d5ce3ffe783c322b4765b790e861727e46bc34b3 | |
| ToppCell | Monocytes-Tissue-resident_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 9.53e-05 | 190 | 56 | 4 | 07215e8f292cb54c670037aaf28393cddbe5548c | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.73e-05 | 191 | 56 | 4 | 6cda82a994f4b205cf54590c979d7c9f3be2b4c8 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.73e-05 | 191 | 56 | 4 | 4257f02856f3510981e9f84d465d91448d6126e2 | |
| ToppCell | COVID-19-Myeloid-DC2|COVID-19 / Condition, Lineage and Cell class | 9.73e-05 | 191 | 56 | 4 | 1304ab7b5713f29f3966ffc020ea1b52e8e2f375 | |
| ToppCell | facs-Skin|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.73e-05 | 191 | 56 | 4 | ae524103331fa53fa82888dbb567fc36abcee7e0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.73e-05 | 191 | 56 | 4 | 7d00796459f4ff0ab7f06a8379b2d34e76b078b2 | |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 9.73e-05 | 191 | 56 | 4 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Rspo3_(Substantia_Innominata_(SI))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 9.83e-05 | 71 | 56 | 3 | 879551882097cfaa4eccf11cb07f3bae68c777c3 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Rspo3_(Substantia_Innominata_(SI))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 9.83e-05 | 71 | 56 | 3 | 8557be86709925cf19125e44c909133fd5adcb62 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.92e-05 | 192 | 56 | 4 | 90274b85f3d612b6a6d435860cd6d049ddeb1d96 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.92e-05 | 192 | 56 | 4 | 35ffe7aa9ffab85eac3326651e901c39d0119650 | |
| ToppCell | 11.5-Distal|11.5 / Age, Tissue, Lineage and Cell class | 9.92e-05 | 192 | 56 | 4 | 169b9ee2377beb9e4ad35bc82bb7a3dafe8f05b6 | |
| ToppCell | Monocytes-Tissue-resident_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 1.01e-04 | 193 | 56 | 4 | 198552810dcac8d0ca63a78badd6702b49ff6edf | |
| ToppCell | MNPs-Dendritic_Cells|MNPs / lung cells shred on cell class, cell subclass, sample id | 1.01e-04 | 193 | 56 | 4 | 0e6b8e179bfe1c6e93137c76c76a91c7782a4989 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 193 | 56 | 4 | 3e3d7cb3e7242ec9c9677e07e303835649852b52 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 193 | 56 | 4 | 040f6bb42aa41d0921371fdda1cc0912c4fe1930 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 193 | 56 | 4 | e468287c8b30c56d1de65e8347ade233ba6cf584 | |
| ToppCell | facs-Trachea-3m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.01e-04 | 193 | 56 | 4 | c5925b3b5d19098e3987789d68a493d7fd548ac9 | |
| ToppCell | facs-Trachea-3m-Epithelial-glandular_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.01e-04 | 193 | 56 | 4 | 6905de261d90dfe3dd2c2cf5b2e26afb2bcc3d5b | |
| ToppCell | facs-Trachea-3m-Epithelial-glandular_epithelial-lung_secretory_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.01e-04 | 193 | 56 | 4 | f73630725f093c646bdaf178c39505c04a16e2c6 | |
| ToppCell | Dendritic_Cells|World / lung cells shred on cell class, cell subclass, sample id | 1.01e-04 | 193 | 56 | 4 | 7792eb6e247af2d7a8f80476f37dcd880922d625 | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 1.03e-04 | 194 | 56 | 4 | 8fc98d2c9d94f3bc6292265e20ab71c4f1f37bb3 | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic|Liver / Manually curated celltypes from each tissue | 1.03e-04 | 194 | 56 | 4 | e6391bc7073831847c469ef0b0c437118e1f151f | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-04 | 194 | 56 | 4 | 59180fe75be386530f1be668a37e4ada2eb19ddc | |
| ToppCell | Adult-Immune-monocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.05e-04 | 195 | 56 | 4 | ea24da6fea1487acb1e56c28c0649858cc0a12bd | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-04 | 195 | 56 | 4 | c26c62522b6e0599f6a1256fefe26e1ed9badcc2 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-04 | 195 | 56 | 4 | 60ba7be0c333ddc57885263a1103faffe06051c7 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.05e-04 | 195 | 56 | 4 | 66e5fd9f3208a06d617c5e994822bf57dceae7e2 | |
| ToppCell | BAL-Mild-Myeloid-cDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.05e-04 | 195 | 56 | 4 | 9e5cf33b5dd455efa464a63d7116786c0786aefd | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-04 | 195 | 56 | 4 | d67950679ccb508016352e9cb4c675bd09eaac5b | |
| ToppCell | Adult-Immune-monocyte|Adult / Lineage, Cell type, age group and donor | 1.07e-04 | 196 | 56 | 4 | 3ef193c5180de3137daf886492e74fc574bc9767 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 196 | 56 | 4 | 291c59b609985167c98a40d4e2caeea2fad74941 | |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.07e-04 | 196 | 56 | 4 | 150554fa06868d29b0608189862eef6505ba757f | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Dendritic_cells|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.07e-04 | 196 | 56 | 4 | f278b144b8deaee0bf41682081b9fbb0b1e82b19 | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-04 | 197 | 56 | 4 | 6806ec223e542f0475303698eb78c1cc527f5c6b | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-04 | 197 | 56 | 4 | 363ae03310f63a586ba3cea2a59f35d5a335a54e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 197 | 56 | 4 | dea1d29154c585ab588e50b83c7c8de7fe24d2d4 | |
| ToppCell | Monocytes-cDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.10e-04 | 197 | 56 | 4 | 3388c104af4c6a05988e102627e0c5e34d9dcc45 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 197 | 56 | 4 | 57dafb3047745a44b2345b8036e159c3641d496e | |
| Disease | protein C measurement, hematological measurement | 9.85e-06 | 3 | 54 | 2 | EFO_0004503, EFO_0004633 | |
| Disease | Obsessive-Compulsive Disorder | 4.91e-05 | 6 | 54 | 2 | C0028768 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.47e-04 | 10 | 54 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.47e-04 | 10 | 54 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.14e-04 | 12 | 54 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | protein C measurement | 4.39e-04 | 17 | 54 | 2 | EFO_0004633 | |
| Disease | anxiety disorder (implicated_via_orthology) | 7.42e-04 | 22 | 54 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | Kallmann Syndrome | 1.04e-03 | 26 | 54 | 2 | C0162809 | |
| Disease | trait in response to apixaban | 1.24e-03 | 115 | 54 | 3 | OBA_2050328 | |
| Disease | chronic obstructive pulmonary disease | 1.57e-03 | 688 | 54 | 6 | EFO_0000341 | |
| Disease | vital capacity | 1.74e-03 | 1236 | 54 | 8 | EFO_0004312 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QQLNAYNRTRYELRE | 166 | Q9UNN8 | |
| YSQDIYENLDLRQRR | 356 | O94929 | |
| TARLRRLVTAYQRSY | 1746 | Q9HCK8 | |
| QQSRRAAVLIQKYYR | 1591 | Q9Y6Y1 | |
| LVLQYRDYQRATQRL | 91 | Q6ZTN6 | |
| QYRSLLVERNRSQRY | 231 | Q2M329 | |
| LVERNRSQRYNLYLQ | 236 | Q2M329 | |
| RAAVLIQQHYRSYRR | 1126 | O94983 | |
| RNEQVEIRAVLYNYR | 841 | P01024 | |
| TARRSLLRYFYRQLL | 276 | Q96M93 | |
| QLSRRQIREYQLYSR | 46 | O60258 | |
| YNINDRQEELRVYLR | 556 | Q4ADV7 | |
| YTVRQLTIQYQEERR | 231 | P35236 | |
| QTERENLRIALRYYN | 96 | P01893 | |
| RLQLRSLQYLERYVC | 766 | Q9ULE6 | |
| YLTRDRRYEVARVLN | 216 | P31274 | |
| RRGRQTYTRYQTLEL | 156 | P31267 | |
| ARGYLARQRYQQMRR | 1936 | Q9UKN7 | |
| QVVLYSIRNQLRYRN | 36 | Q658Y4 | |
| RLLYTDFRQRYRILN | 761 | A7E2Y1 | |
| VRRNAVLAIYTIYRN | 151 | P53618 | |
| SNDTYLYRVQRLIRS | 56 | Q9H114 | |
| YRIRQQTDIYKQIRA | 461 | Q7Z3B3 | |
| RYCRLLNAVRIIQVY | 86 | A8MTL0 | |
| KYLQLLRTSAQQRYR | 146 | Q86WI3 | |
| RRRGRQTYSRYQTLE | 146 | P17481 | |
| RRRGRQIYSRYQTLE | 141 | P09630 | |
| VTAVIRSRRYYREQR | 216 | Q8IZS5 | |
| TDQLSRRLIRTYQLY | 61 | P55075 | |
| LRSFRELTYQYRQNI | 606 | Q96EP1 | |
| QRAQRNSLLYYSEER | 331 | Q6ZN84 | |
| YRLRLVYNNGLRTEQ | 111 | Q9BQW3 | |
| LYGRIYRAARNRILN | 216 | P28221 | |
| QNSRRYIRNTTRYLL | 146 | B2RV13 | |
| RYRLQRREDYTRYNQ | 36 | Q9NV31 | |
| RREDYTRYNQLSRAV | 41 | Q9NV31 | |
| ETRRNGYSRRQQELY | 551 | P55289 | |
| RNYARRQKHLQRYSL | 371 | Q96BU1 | |
| RDVQYFLYIRNSKRR | 146 | P15509 | |
| LQQQYELYRERLLQR | 861 | Q53GL7 | |
| QLRREGIRYARIQLY | 646 | Q6PCB5 | |
| LARQIRARYEEVQRY | 56 | Q504Y2 | |
| NIVITRYNNRTYRID | 416 | Q8TC59 | |
| VSATVIQRAYRRYRL | 1891 | Q15858 | |
| YELERRFRQQRYLSA | 141 | O95096 | |
| YHYVRRTRQITRYRN | 156 | Q8N4L1 | |
| LRTTYRSLLQCQYRN | 391 | P34969 | |
| YLLRRQIRTVIQYQT | 26 | O95476 | |
| SSYVARQYRSLRVRI | 271 | Q6ZS11 | |
| ESAYYLRSRQRRQPR | 101 | Q5JTV8 | |
| RRHYLERRNYIIQNI | 261 | Q9H0U9 | |
| LTREVYRSYRQLRTQ | 141 | O43278 | |
| LNGRTRRYTDIQLQY | 2656 | Q6N022 | |
| QRELEQLGRQLRYYR | 1336 | Q15149 | |
| ANIYLQTLRDRRLYI | 701 | Q8NDW8 | |
| IIQRAYKNYRLRRND | 1631 | Q01118 | |
| RLEAVQRYIRELQYN | 121 | Q7L8A9 | |
| RIYYLSQERNRRASI | 896 | Q15849 | |
| NLRRRFRENLIYTYI | 66 | O00159 |